Trials / Completed
CompletedNCT00958165
Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CFEAS- AC) for the Treatment of Symptomatic Atrial Fibrillation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- CardioFocus · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and effectiveness of the endoscopic ablation system - adaptive contact (EAS-AC) in treated paroxysmal atrial fibrillation (PAF) with pulmonary vein isolation (PVI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CardioFocus EAS-AC | PVI for PAF |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2012-03-01
- Completion
- 2012-05-01
- First posted
- 2009-08-13
- Last updated
- 2016-08-30
- Results posted
- 2016-07-27
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00958165. Inclusion in this directory is not an endorsement.